Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription 11.03.2019 1 Am J Clin Oncol 1 Ann Oncol 5 Ann Surg Oncol 3 Anticancer Res 1 Br J Cancer 2 Br J Surg 1 Cancer 1 Cancer Lett 8 Dis Colon Rectum 2 Eur J Cancer 4 Eur J Gastroenterol Hepatol 8 Eur J Surg Oncol 2 Gastroenterology 1 Hum Pathol 2 Int J Cancer 1 Int J Oncol 1 J Surg Oncol 3 Oncogene 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Clin Oncol

1. LLOYD S, Baraghoshi D, Tao R, Garrido-Laguna I, et al
   Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival.
   Am J Clin Oncol. 2019 Mar 5. doi: 10.1097/COC.0000000000000529.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

2. SANTOS C, Azuara D, Vieitez JM, Paez D, et al
   Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.
   Ann Oncol. 2019 Mar 6. pii: 5370172. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg Oncol

3. HUPKENS BJP, Maas M, Martens MH, van der Sande ME, et al
   Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?
   Ann Surg Oncol. 2018;25:197-203.
   PubMed     Text format     Abstract available
   
   
4. SOTIRCHOS VS, Fujisawa S, Vakiani E, Solomon SB, et al
   Fluorescent Tissue Assessment of Colorectal Cancer Liver Metastases Ablation Zone: A Potential Real-Time Biomarker of Complete Tumor Ablation.
   Ann Surg Oncol. 2019 Mar 4. pii: 10.1245/s10434-018-07133.
   PubMed     Text format     Abstract available
   
   
5. MEGE D, Sabbagh C, Manceau G, Karoui M, et al
   Response to Dr. Veld et al. Regarding the Manuscript Titled "What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score An
   Ann Surg Oncol. 2019 Mar 6. pii: 10.1245/s10434-019-07281.
   PubMed     Text format    
   
   
6. VELD JV, Amelung FJ, van Hooft JE, Tanis PJ, et al
   Letter to the Editor Regarding 'What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical
   Ann Surg Oncol. 2019 Mar 7. pii: 10.1245/s10434-019-07279.
   PubMed     Text format    
   
   
7. YOSHIDA T, Shida D, Taniguchi H, Tsukamoto S, et al
   Long-Term Outcomes Following Partial Versus Complete Cystectomy in Advanced Colorectal Cancer with Regarding to the Extent of Bladder Invasion.
   Ann Surg Oncol. 2019 Mar 7. pii: 10.1245/s10434-019-07276.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

8. ARAKAWA K, Hata K, Nozawa H, Kawai K, et al
   Molecular Subtypes Are Frequently Discordant Between Lesions in Patients With Synchronous Colorectal Cancer: Molecular Analysis of 59 Patients.
   Anticancer Res. 2019;39:1425-1432.
   PubMed     Text format     Abstract available
   
   
9. NAGATA T, Fukuda KI, Tamai M, Taniguchi A, et al
   Early Neuropathy Related to Oxaliplatin Treatment in Advanced and Recurrent Colorectal Cancer.
   Anticancer Res. 2019;39:1347-1353.
   PubMed     Text format     Abstract available
   
   
10. YANO Y, Yoshimatsu K, Yokomizo H, Sagawa M, et al
    Enhancement of the Marginal Area in Colorectal Cancer Liver Metastasis on Computed Tomography Correlates With Microvessel Density and Clinicopathological Factors.
    Anticancer Res. 2019;39:1301-1308.
    PubMed     Text format     Abstract available
    
    

    
    Br J Cancer

11. TOMITA N, Kunieda K, Maeda A, Hamada C, et al
    Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study.
    Br J Cancer. 2019 Mar 5. pii: 10.1038/s41416-019-0410.
    PubMed     Text format     Abstract available
    
    

    
    Br J Surg

12. OKUNO M, Goumard C, Mizuno T, Kopetz S, et al
    Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
    Br J Surg. 2018;105:1200-1209.
    PubMed     Text format     Abstract available
    
    
13. MARGONIS GA, Sasaki K, Gholami S, Kim Y, et al
    Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
    Br J Surg. 2018;105:1210-1220.
    PubMed     Text format     Abstract available
    
    

    
    Cancer

14. WU Y, Liang Y, Zhou Q, Liu H, et al
    Effectiveness of a short message service intervention to motivate people with positive results in preliminary colorectal cancer screening to undergo colonoscopy: A randomized controlled trial.
    Cancer. 2019 Mar 2. doi: 10.1002/cncr.32043.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

15. WANG Q, Feng Y, Peng W, Ji D, et al
    Long noncoding RNA Linc02023 regulates PTEN stability and suppresses tumorigenesis of colorectal cancer in a PTEN-dependent pathway.
    Cancer Lett. 2019 Mar 5. pii: S0304-3835(19)30127.
    PubMed     Text format     Abstract available
    
    

    
    Dis Colon Rectum

16. MOLOO H, Musselman R
    Building Decision Analysis Tools Through Systematic Review of the Literature: The Importance of Study Quality.
    Dis Colon Rectum. 2019;62:1-2.
    PubMed     Text format    
    
    
17. RINK AD, Kneist W
    How to Report on Distal Resection Margins in Trials on Rectal Cancer Surgery.
    Dis Colon Rectum. 2019;62:e1-e2.
    PubMed     Text format    
    
    
18. PERSIANI R, Biondi A
    The Authors Reply.
    Dis Colon Rectum. 2019;62:e2-e3.
    PubMed     Text format    
    
    
19. BAGUENA G, Pellino G, Frasson M, Rosello S, et al
    Prognostic Impact of pT Stage and Peritoneal Invasion in Locally Advanced Colon Cancer.
    Dis Colon Rectum. 2019 Mar 4. doi: 10.1097/DCR.0000000000001367.
    PubMed     Text format     Abstract available
    
    
20. NAVANEETHAN U
    Chromoendoscopy: Coloring the Colon to Predict Submucosal Invasive Colon Cancer.
    Dis Colon Rectum. 2019;62:389-391.
    PubMed     Text format    
    
    
21. PETERS WR
    What Every Colorectal Surgeon Should Know About the New American Cancer Society's Colorectal Cancer Screening Guidelines.
    Dis Colon Rectum. 2019;62:397-398.
    PubMed     Text format    
    
    
22. ALVAREZ-GONZALEZ MA, Pantaleon MA, Flores-Le Roux JA, Zaffalon D, et al
    Randomized Clinical Trial: A Normocaloric Low-Fiber Diet the Day Before Colonoscopy Is the Most Effective Approach to Bowel Preparation in Colorectal Cancer Screening Colonoscopy.
    Dis Colon Rectum. 2019;62:491-497.
    PubMed     Text format     Abstract available
    
    
23. KONG JC, Guerra GR, Pham T, Mitchell C, et al
    Prognostic Impact of Tumor-Infiltrating Lymphocytes in Primary and Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.
    Dis Colon Rectum. 2019;62:498-508.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

24. TEJPAR S, Yan P, Piessevaux H, Dietrich D, et al
    Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trial.
    Eur J Cancer. 2018;99:66-77.
    PubMed     Text format     Abstract available
    
    
25. KOSUMI K, Hamada T, Zhang S, Liu L, et al
    Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.
    Eur J Cancer. 2019;111:82-93.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Gastroenterol Hepatol

26. JOOSTE V, Bouvier AM, Bossard N, Uhry Z, et al
    Trends in probabilities of death owing to cancer and owing to other causes in patients with colon cancer.
    Eur J Gastroenterol Hepatol. 2019 Mar 1. doi: 10.1097/MEG.0000000000001387.
    PubMed     Text format     Abstract available
    
    
27. DOS SANTOS CEO, Malaman D, Yoshida N, Pereira-Lima JC, et al
    Blue laser imaging: a new image-enhanced endoscopy for the diagnosis of colorectal lesions.
    Eur J Gastroenterol Hepatol. 2018;30:1514-1520.
    PubMed     Text format     Abstract available
    
    
28. GKOLFAKIS P, Tziatzios G, Facciorusso A, Muscatiello N, et al
    Meta-analysis indicates that add-on devices and new endoscopes reduce colonoscopy adenoma miss rate.
    Eur J Gastroenterol Hepatol. 2018;30:1482-1490.
    PubMed     Text format     Abstract available
    
    
29. ISLAM MM, Poly TN, Walther BA, Dubey NK, et al
    Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 Jul 19. doi: 10.1097/MEG.0000000000001198.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

30. GREMONPREZ F, Gossye H, Ceelen W
    Use of hyperthermia versus normothermia during intraperitoneal chemoperfusion with oxaliplatin for colorectal peritoneal carcinomatosis: A propensity score matched analysis.
    Eur J Surg Oncol. 2019;45:366-370.
    PubMed     Text format     Abstract available
    
    
31. CHUNG E, Kang D, Lee HS, Cho ES, et al
    Accuracy of pelvic MRI in measuring tumor height in rectal cancer patients with or without preoperative chemoradiotherapy.
    Eur J Surg Oncol. 2019;45:324-330.
    PubMed     Text format     Abstract available
    
    
32. CEELEN W
    HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?
    Eur J Surg Oncol. 2019;45:400-402.
    PubMed     Text format     Abstract available
    
    
33. OEMRAWSINGH A, de Boer NL, Brandt-Kerkhof ARM, Verhoef C, et al
    Short-term complications in elderly patients undergoing CRS and HIPEC: A single center's initial experience.
    Eur J Surg Oncol. 2019;45:383-388.
    PubMed     Text format     Abstract available
    
    
34. VAN DER WERF LR, Wassenaar E, de Niet A, Lalezari F, et al
    The impact of radiological retroperitoneal lymphadenopathy on survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases.
    Eur J Surg Oncol. 2019;45:376-382.
    PubMed     Text format     Abstract available
    
    
35. KOMORI K, Fujita S, Mizusawa J, Kanemitsu Y, et al
    Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).
    Eur J Surg Oncol. 2019;45:336-340.
    PubMed     Text format     Abstract available
    
    
36. SVERRISSON I, Folkvaljon F, Chabok A, Stattin P, et al
    Anastomotic leakage after anterior resection in patients with rectal cancer previously irradiated for prostate cancer.
    Eur J Surg Oncol. 2019;45:341-346.
    PubMed     Text format     Abstract available
    
    
37. BONIFACIO C, Vigano L, Felisaz P, Lopci E, et al
    Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases.
    Eur J Surg Oncol. 2019;45:347-352.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

38. RAMKISSOON R, Anderson JC
    Individuals with Advanced Adenomas are at Increased Risk for Colorectal Cancer.
    Gastroenterology. 2019 Mar 5. pii: S0016-5085(19)32515.
    PubMed     Text format    
    
    
39. DANG H, Boonstra JJ, Langers AMJ
    An unexpected recurrence after endoscopic resection of low-risk T1 colorectal cancer.
    Gastroenterology. 2019 Feb 27. pii: S0016-5085(19)32491.
    PubMed     Text format    
    
    

    
    Hum Pathol

40. HUHNS M, Krohn S, Murua Escobar H, Prall F, et al
    Genomic heterogeneity in primary colorectal carcinomas and their metastases: born bad or brought up a villain?
    Hum Pathol. 2018;74:54-63.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

41. ZHU L, Yan F, Wang Z, Dong H, et al
    Genome-wide DNA methylation profiling of primary colorectal laterally spreading tumors identifies disease-specific epimutations on common pathways.
    Int J Cancer. 2018;143:2488-2498.
    PubMed     Text format     Abstract available
    
    
42. LI S, Shi X, Chen M, Xu N, et al
    Angiogenin promotes colorectal cancer metastasis via tiRNA production.
    Int J Cancer. 2019 Mar 3. doi: 10.1002/ijc.32245.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

43. CHENG Y, Lu Y, Zhang D, Lian S, et al
    Metastatic cancer cells compensate for low energy supplies in hostile microenvironments with bioenergetic adaptation and metabolic reprogramming.
    Int J Oncol. 2018;53:2590-2604.
    PubMed     Text format     Abstract available
    
    

    
    J Surg Oncol

44. SCHLICK CJR, Merkow RP, Bentrem DJ
    Nonresectional regional therapies for metastatic colorectal cancer to the liver.
    J Surg Oncol. 2019 Mar 1. doi: 10.1002/jso.25423.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

45. MUNOZ-GALVAN S, Lucena-Cacace A, Perez M, Otero-Albiol D, et al
    Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment.
    Oncogene. 2019;38:1309-1323.
    PubMed     Text format     Abstract available
    
    
46. YANG JB, Zhao ZB, Liu QZ, Hu TD, et al
    FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.
    Oncogene. 2018;37:1192-1204.
    PubMed     Text format     Abstract available
    
    
47. CUYAS E, Fernandez-Arroyo S, Verdura S, Garcia RA, et al
    Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism.
    Oncogene. 2018;37:963-970.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

48. ESTEVA M, Ruiz-Diaz M, Sanchez MA, Pertega S, et al
    Emergency presentation of colorectal patients in Spain.
    PLoS One. 2018;13:e0203556.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: